date,title,source
Oct-22-18,Weekly CEO Buys Highlight,GuruFocus.com
Oct-30-18,"CymaBay to Report Third Quarter 2018 Financial Results on Tuesday, November 6",GlobeNewswire
Oct-30-18,CymaBay Announces the Initiation of the Seladelpar Global Phase 3 Registration Study (ENHANCE) for the Treatment of Primary Biliary Cholangitis and Additional Corporate Updates,GlobeNewswire
Nov-06-18,CymaBay Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
